CD4 and graft versus host disease: These findings provide evidence that recipient BALB/c mice transplanted with CD4 T cells from TCF-1 cKO mice exhibit increased levels of serum cytokines linked to GvHD severity from day 1 to day 14, but these levels reduce to WT levels at day 14 onward.